|
1
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng CKY, Pemberton HN and Reis-Filho JS:
Breast cancer intratumor genetic heterogeneity: Causes and
implications. Expert Rev Anticancer Ther. 12:1021–1032. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chimal-Ramírez GK, Espinoza-Sánchez NA and
Fuentes-Pananá EM: Protumor activities of the immune response:
Insights in the mechanisms of immunological shift, oncotraining,
and oncopromotion. J Oncol. 2013:8359562013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller FR, Miller BE and Heppner GH:
Characterization of metastatic heterogeneity among subpopulations
of a single mouse mammary tumor: Heterogeneity in phenotypic
stability. Invasion Metastasis. 3:22–31. 1983.PubMed/NCBI
|
|
7
|
Calbo J, van Montfort E, Proost N, van
Drunen E, Beverloo HB, Meuwissen R and Berns A: A functional role
for tumor cell heterogeneity in a mouse model of small cell lung
cancer. Cancer Cell. 19:244–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu M, Pastor-Pareja JC and Xu T:
Interaction between Ras(V12) and scribbled clones induces tumour
growth and invasion. Nature. 463:545–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cleary AS, Leonard TL, Gestl SA and
Gunther EJ: Tumour cell heterogeneity maintained by cooperating
subclones in Wnt-driven mammary cancers. Nature. 508:113–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bose D, Zimmerman LJ, Pierobon M,
Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, et
al: Chemoresistant colorectal cancer cells and cancer stem cells
mediate growth and survival of bystander cells. Br J Cancer.
105:1759–1767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mukherjee S, Manna A, Bhattacharjee P,
Mazumdar M, Saha S, Chakraborty S, Guha D, Adhikary A, Jana D,
Gorain M, et al: Non-migratory tumorigenic intrinsic cancer stem
cells ensure breast cancer metastasis by generation of CXCR4(+)
migrating cancer stem cells. Oncogene. 35:4937–4948. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaffer CL, Marjanovic ND, Lee T, Bell G,
Kleer CG, Reinhardt F, D'Alessio AC, Young RA and Weinberg RA:
Poised chromatin at the ZEB1 promoter enables breast cancer cell
plasticity and enhances tumorigenicity. Cell. 154:61–74. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: Cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santisteban M, Reiman JM, Asiedu MK,
Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC,
Manjili MH, et al: Immune-induced epithelial to mesenchymal
transition in vivo generates breast cancer stem cells. Cancer Res.
69:2887–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig
R and Kasimir-Bauer S: Stem cell and epithelial-mesenchymal
transition markers are frequently overexpressed in circulating
tumor cells of metastatic breast cancer patients. Breast Cancer
Res. 11:R462009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lacroix M and Leclercq G: Relevance of
breast cancer cell lines as models for breast tumours: An update.
Breast Cancer Res Treat. 83:249–289. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McAllister SS and Weinberg RA: The
tumour-induced systemic environment as a critical regulator of
cancer progression and metastasis. Nat Cell Biol. 16:717–727. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luker KE and Luker GD: Functions of CXCL12
and CXCR4 in breast cancer. Cancer Lett. 238:30–41. 2006.
View Article : Google Scholar
|
|
22
|
Ali S and Lazennec G: Chemokines: Novel
targets for breast cancer metastasis. Cancer Metastasis Rev.
26:401–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
García-Rocha R, Moreno-Lafont M,
Mora-García ML, Weiss-Steider B, Montesinos JJ, Piña-Sánchez P and
Monroy-García A: Mesenchymal stromal cells derived from cervical
cancer tumors induce TGF-β1 expression and IL-10 expression and
secretion in the cervical cancer cells, resulting in protection
from cytotoxic T cell activity. Cytokine. 76:382–390. 2015.
View Article : Google Scholar
|
|
24
|
Chimal-Ramírez GK, Espinoza-Sánchez NA and
Fuentes-Pananá EM: A role for the inflammatory mediators Cox-2 and
metalloproteinases in cancer stemness. Anticancer Agents Med Chem.
15:837–855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mukaida N, Sasaki S and Baba T: Chemokines
in cancer development and progression and their potential as
targeting molecules for cancer treatment. Mediators Inflamm.
2014:1703812014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aliper AM, Frieden-Korovkina VP, Buzdin A,
Roumiantsev SA and Zhavoronkov A: A role for G-CSF and GM-CSF in
nonmyeloid cancers. Cancer Med. 3:737–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soria G, Ofri-Shahak M, Haas I,
Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P,
Meshel T, Shabtai E, Gutman M, et al: Inflammatory mediators in
breast cancer: Coordinated expression of TNFα & IL-1β with CCL2
& CCL5 and effects on epithelial-to-mesenchymal transition. BMC
Cancer. 11:1302011. View Article : Google Scholar
|
|
28
|
Schadendorf D, Möller A, Algermissen B,
Worm M, Sticherling M and Czarnetzki BM: IL-8 produced by human
malignant melanoma cells in vitro is an essential autocrine growth
factor. J Immunol. 151:2667–2675. 1993.PubMed/NCBI
|
|
29
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schoenhals M, Kassambara A, De Vos J, Hose
D, Moreaux J and Klein B: Embryonic stem cell markers expression in
cancers. Biochem Biophys Res Commun. 383:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weiswald LB, Bellet D and Dangles-Marie V:
Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Manuel Iglesias J, Beloqui I,
Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon
A, Menendez JA, Dopazo J, et al: Mammosphere formation in breast
carcinoma cell lines depends upon expression of E-cadherin. PLoS
One. 8:e772812013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Greaves M and Maley CC: Clonal evolution
in cancer. Nature. 481:306–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marusyk A, Tabassum DP, Altrock PM,
Almendro V, Michor F and Polyak K: Non-cell-autonomous driving of
tumour growth supports sub-clonal heterogeneity. Nature. 514:54–58.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kasimir-Bauer S, Hoffmann O, Wallwiener D,
Kimmig R and Fehm T: Expression of stem cell and
epithelial-mesenchymal transition markers in primary breast cancer
patients with circulating tumor cells. Breast Cancer Res.
14:R152012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oon ML, Thike AA, Tan SY and Tan PH:
Cancer stem cell and epithelial-mesenchymal transition markers
predict worse outcome in metaplastic carcinoma of the breast.
Breast Cancer Res Treat. 150:31–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McFarlane S, Coulter JA, Tibbits P,
O'Grady A, McFarlane C, Montgomery N, Hill A, McCarthy HO, Young
LS, Kay EW, et al: CD44 increases the efficiency of distant
metastasis of breast cancer. Oncotarget. 6:11465–11476. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei
X, Gao J, Zhao Z and Liu C: Oct-4 and Nanog promote the
epithelial-mesenchymal transition of breast cancer stem cells and
are associated with poor prognosis in breast cancer patients.
Oncotarget. 5:10803–10815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh AK, Arya RK, Trivedi AK, Sanyal S,
Baral R, Dormond O, Briscoe DM and Datta D: Chemokine receptor
trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Cytokine Growth Factor Rev. 24:41–49. 2013. View Article : Google Scholar
|
|
41
|
Guo F, Wang Y, Liu J, Mok SC, Xue F and
Zhang W: CXCL12/CXCR4: A symbiotic bridge linking cancer cells and
their stromal neighbors in oncogenic communication networks.
Oncogene. 35:816–826. 2016. View Article : Google Scholar
|
|
42
|
Liu H, Patel MR, Prescher JA, Patsialou A,
Qian D, Lin J, Wen S, Chang YF, Bachmann MH, Shimono Y, et al:
Cancer stem cells from human breast tumors are involved in
spontaneous metastases in orthotopic mouse models. Proc Natl Acad
Sci USA. 107:18115–18120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sheridan C, Kishimoto H, Fuchs RK,
Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S and
Nakshatri H: CD44+/CD24− breast cancer cells
exhibit enhanced invasive properties: An early step necessary for
metastasis. Breast Cancer Res. 8:R592006. View Article : Google Scholar
|
|
44
|
Palena C, Hamilton DH and Fernando RI:
Influence of IL-8 on the epithelial-mesenchymal transition and the
tumor microenvironment. Future Oncol. 8:713–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen W, Gao Q, Han S, Pan F and Fan W: The
CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal
transition by cooperatively activating STAT3-Twist signaling.
Tumour Biol. 36:973–981. 2015. View Article : Google Scholar
|
|
46
|
Espinoza-Sánchez NA, Chimal-Ramírez GK,
Mantilla A and Fuentes-Pananá EM: IL-1β, IL-8 and matrix
metalloproteinases -1, -2 and -10 are enriched upon monocyte-breast
cancer cell co-cultivation in a Matrigel-based three dimensional
system. Front Immunol. 8:2052017. View Article : Google Scholar
|
|
47
|
Ning Y, Manegold PC, Hong YK, Zhang W,
Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, et al:
Interleukin-8 is associated with proliferation, migration,
angiogenesis and chemosensitivity in vitro and in vivo in colon
cancer cell line models. Int J Cancer. 128:2038–2049. 2011.
View Article : Google Scholar :
|
|
48
|
Saji H, Koike M, Yamori T, Saji S, Seiki
M, Matsushima K and Toi M: Significant correlation of monocyte
chemoattractant protein-1 expression with neovascularization and
progression of breast carcinoma. Cancer. 92:1085–1091. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao
Z and Zhang J: CCR2 expression correlates with prostate cancer
progression. J Cell Biochem. 101:676–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kudo-Saito C, Shirako H, Ohike M,
Tsukamoto N and Kawakami Y: CCL2 is critical for immunosuppression
to promote cancer metastasis. Clin Exp Metastasis. 30:393–405.
2013. View Article : Google Scholar
|
|
51
|
Fang WB, Yao M, Brummer G, Acevedo D,
Alhakamy N, Berkland C and Cheng N: Targeted gene silencing of CCL2
inhibits triple negative breast cancer progression by blocking
cancer stem cell renewal and M2 macrophage recruitment. Oncotarget.
7:49349–49367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Velasco-Velázquez MA, Popov VM, Lisanti MP
and Pestell RG: The role of breast cancer stem cells in metastasis
and therapeutic implications. Am J Pathol. 179:2–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
